181 related articles for article (PubMed ID: 34565398)
1. Highly sensitive and portable mRNA detection platform for early cancer detection.
Li H; Warden AR; Su W; He J; Zhi X; Wang K; Zhu L; Shen G; Ding X
J Nanobiotechnology; 2021 Sep; 19(1):287. PubMed ID: 34565398
[TBL] [Abstract][Full Text] [Related]
2. A signal-amplifiable biochip quantifies extracellular vesicle-associated RNAs for early cancer detection.
Hu J; Sheng Y; Kwak KJ; Shi J; Yu B; Lee LJ
Nat Commun; 2017 Nov; 8(1):1683. PubMed ID: 29162835
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Vesicular Analysis of Glypican 1 mRNA and Protein for Pancreatic Cancer Diagnosis and Prognosis.
Li H; Chiang CL; Kwak KJ; Wang X; Doddi S; Ramanathan LV; Cho SM; Hou YC; Cheng TS; Mo X; Chang YS; Chang HL; Cheng W; Tsai WN; Nguyen LTH; Pan J; Ma Y; Rima XY; Zhang J; Reategui E; Chu YS; Chang PM; Chang PH; Huang CF; Wang CH; Shan YS; Li CP; Fleisher M; Lee LJ
Adv Sci (Weinh); 2024 Mar; 11(11):e2306373. PubMed ID: 38204202
[TBL] [Abstract][Full Text] [Related]
4. Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma.
Lu H; Niu F; Liu F; Gao J; Sun Y; Zhao X
Cancer Med; 2017 Jun; 6(6):1181-1191. PubMed ID: 28440066
[TBL] [Abstract][Full Text] [Related]
5. Combined Exosomal GPC1, CD82, and Serum CA19-9 as Multiplex Targets: A Specific, Sensitive, and Reproducible Detection Panel for the Diagnosis of Pancreatic Cancer.
Xiao D; Dong Z; Zhen L; Xia G; Huang X; Wang T; Guo H; Yang B; Xu C; Wu W; Zhao X; Xu H
Mol Cancer Res; 2020 Feb; 18(2):300-310. PubMed ID: 31662449
[TBL] [Abstract][Full Text] [Related]
6. Glypican-1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases.
Lucien F; Lac V; Billadeau DD; Borgida A; Gallinger S; Leong HS
Oncotarget; 2019 Feb; 10(10):1045-1055. PubMed ID: 30800217
[TBL] [Abstract][Full Text] [Related]
7. Quantification of GPC1(+) Exosomes Based on MALDI-TOF MS In Situ Signal Amplification for Pancreatic Cancer Discrimination and Evaluation.
Yan S; Zheng H; Zhao J; Gao M; Zhang X
Anal Chem; 2023 Jul; 95(27):10196-10203. PubMed ID: 37368911
[TBL] [Abstract][Full Text] [Related]
8. Overhang molecular beacons encapsulated in tethered cationic lipoplex nanoparticles for detection of single-point mutation in extracellular vesicle-associated RNAs.
Hu J; Kwak KJ; Shi J; Yu B; Sheng Y; Lee LJ
Biomaterials; 2018 Nov; 183():20-29. PubMed ID: 30145409
[TBL] [Abstract][Full Text] [Related]
9. Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma.
Wang X; Kwak KJ; Yang Z; Zhang A; Zhang X; Sullivan R; Lin D; Lee RL; Castro C; Ghoshal K; Schmidt C; Lee LJ
PLoS One; 2018; 13(6):e0198552. PubMed ID: 29879168
[TBL] [Abstract][Full Text] [Related]
10. Self-assembly of DNA-gold nanoaggregate for visual detection of thymidine kinase 1 (TK1) mRNA via lateral flow assay.
Wang J; Shi L; Tang Q; Zhu X; Wu M; Liu W; Li B; Jin Y
Mikrochim Acta; 2023 Nov; 190(11):454. PubMed ID: 37910317
[TBL] [Abstract][Full Text] [Related]
11. A portable SERS reader coupled with catalytic hairpin assembly for sensitive microRNA-21 lateral flow sensing.
Wang W; Li Y; Nie A; Fan GC; Han H
Analyst; 2021 Feb; 146(3):848-854. PubMed ID: 33319869
[TBL] [Abstract][Full Text] [Related]
12. Dual Tumor Exosome Biomarker Co-recognitions Based Nanoliquid Biopsy for the Accurate Early Diagnosis of Pancreatic Cancer.
Yu Z; Yang Y; Fang W; Hu P; Liu Y; Shi J
ACS Nano; 2023 Jun; 17(12):11384-11395. PubMed ID: 37288703
[TBL] [Abstract][Full Text] [Related]
13. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
Zhou CY; Dong YP; Sun X; Sui X; Zhu H; Zhao YQ; Zhang YY; Mason C; Zhu Q; Han SX
Cancer Med; 2018 Nov; 7(11):5525-5533. PubMed ID: 30358133
[TBL] [Abstract][Full Text] [Related]
14. Correlation of glypican-1 expression with TGF-beta, BMP, and activin receptors in pancreatic ductal adenocarcinoma.
Kayed H; Kleeff J; Keleg S; Jiang X; Penzel R; Giese T; Zentgraf H; Büchler MW; Korc M; Friess H
Int J Oncol; 2006 Nov; 29(5):1139-48. PubMed ID: 17016645
[TBL] [Abstract][Full Text] [Related]
15. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
Melo SA; Luecke LB; Kahlert C; Fernandez AF; Gammon ST; Kaye J; LeBleu VS; Mittendorf EA; Weitz J; Rahbari N; Reissfelder C; Pilarsky C; Fraga MF; Piwnica-Worms D; Kalluri R
Nature; 2015 Jul; 523(7559):177-82. PubMed ID: 26106858
[TBL] [Abstract][Full Text] [Related]
16. Codetection of Proteins and RNAs on Extracellular Vesicles for Pancreatic Cancer Early Diagnosis.
He J; Long J; Zhai C; Xu J; Bao K; Su W; Jiang L; Shen G; Ding X
Anal Chem; 2024 Apr; 96(17):6618-6627. PubMed ID: 38626343
[TBL] [Abstract][Full Text] [Related]
17. Catalytic hairpin assembly-assisted lateral flow assay for visual determination of microRNA-21 using gold nanoparticles.
Wang W; Nie A; Lu Z; Li J; Shu M; Han H
Mikrochim Acta; 2019 Aug; 186(9):661. PubMed ID: 31471777
[TBL] [Abstract][Full Text] [Related]
18. Validation of Biomarkers for Early Detection of Pancreatic Cancer: Summary of The Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection Workshop.
Young MR; Wagner PD; Ghosh S; Rinaudo JA; Baker SG; Zaret KS; Goggins M; Srivastava S
Pancreas; 2018 Feb; 47(2):135-141. PubMed ID: 29346214
[TBL] [Abstract][Full Text] [Related]
19. Detection of serum EphA2-EVs for pancreatic cancer diagnosis by light initiated chemiluminescent assay.
Li W; Yang X; Bai T; Xu J; Qian Z; Li Y; Guo Z; Zhu Y
Anal Methods; 2022 Mar; 14(13):1335-1341. PubMed ID: 35289811
[TBL] [Abstract][Full Text] [Related]
20. A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer.
Lai X; Wang M; McElyea SD; Sherman S; House M; Korc M
Cancer Lett; 2017 May; 393():86-93. PubMed ID: 28232049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
